Home
Investing
Stocks
USA
NASDAQ
Hepion Pharmaceuticals Inc (HEPA) Quote

Hepion Pharmaceuticals Inc (HEPA)

0.135

0.00

(0.00%)

Closed July 16 4:00PM

15 min delayed - Upgrade to Realtime

0.00

(0.00%)

After Hours: -

15 min delayed - Upgrade to Realtime

Hepion Pharmaceuticals Inc (HEPA) Quote

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Current Price

0.135

( - )

Bid

0.1331

Ask

0.143

Volume

0.00 Day's Range 0.00

0.1081 52 Week Range 56.00

Market Cap

1.482M

Previous Close

0.135

Open

Last Trade

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

1,114,322

Shares Outstanding

10,976,276

Dividend Yield

PE Ratio

-0.11

Earnings Per Share (EPS)

-1.2

Revenue

Net Profit

-13.19M

Hepion Pharmaceuticals Inc is a biopharmaceutical company that focuses primarily on the development of drug therapy for the treatment of chronic liver diseases. This therapeutic approach targets fibrosis and hepatocellular carcinoma associated with non-alcoholic steatohepatitis, viral hepatitis, and... Hepion Pharmaceuticals Inc is a biopharmaceutical company that focuses primarily on the development of drug therapy for the treatment of chronic liver diseases. This therapeutic approach targets fibrosis and hepatocellular carcinoma associated with non-alcoholic steatohepatitis, viral hepatitis, and other liver diseases. Its cyclophilin inhibitor, Rencofilstat, is being developed to offer benefits to address these multiple complex pathologies. Rencofilstat is a pan cyclophilin inhibitor that targets multiple pathologic pathways involved in the progression of liver disease. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.hepion.com

Headquarters

Wilmington, Delaware, USA

Founded

Hepion Pharmaceuticals Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker HEPA. The last closing price for Hepion Pharmaceuticals was $0.14. Over the last year, Hepion Pharmaceuticals shares have traded in a share price range of $ 0.1081 to $ 56.00.

Hepion Pharmaceuticals currently has 10,976,276 shares outstanding. The market capitalization of Hepion Pharmaceuticals is $1.48 million. Hepion Pharmaceuticals has a price to earnings ratio (PE ratio) of -0.11.

Hepion Pharmaceuticals Successfully Completes Application to the OTCQB

MORRISTOWN, N.J., June 25, 2025 (GLOBE NEWSWIRE) -- Hepion Pharmaceuticals, Inc. (OTCQB:HEPA), a clinical...

Hepion Pharmaceuticals Announces Dr. Kaouthar Lbiati as Interim Chief Executive Officer

MORRISTOWN, N.J., June 16, 2025 (GLOBE NEWSWIRE) -- Hepion Pharmaceuticals, Inc. (OTC:HEPA), a clinical stage...

Form 8-K - Current report

Hepion Pharmaceuticals Announces Receipt of Delisting Notification from Nasdaq

MORRISTOWN, N.J., May 12, 2025 (GLOBE NEWSWIRE) -- Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA), a clinical...

Hepion Pharmaceuticals Executes Binding Letter of Intent with New Day Diagnostics to Commercialize Diagnostic Tests for Celiac Disease, Respiratory Multiplex, H. Pylori and HCC

MORRISTOWN, N.J., May 07, 2025 (GLOBE NEWSWIRE) -- Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA), a clinical...

Form 8-K - Current report

Form PRER14A - Preliminary Proxy Soliciting materials

Form 8-K - Current report

Hepion Pharmaceuticals Announces Reverse Stock Split

Shares Expected to Begin Trading on Split-Adjusted Basis on March 18, 2025 MORRISTOWN, N.J., March 14, 2025...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0	0	0.135	0.135	0.135	0	0	CS
4	0	0	0.135	0.135	0.135	0	0	CS
12	-0.146	-51.9572953737	0.281	0.49	0.1081	1114322	0.32499008	CS
26	-21.865	-99.3863636364	22	26.395	0.1081	11623549	5.4508677	CS
52	-49.865	-99.73	50	56	0.1081	5773591	5.75875308	CS
156	-602.865	-99.9776119403	603	1192.7	0.1081	2073488	49.19409408	CS
260	-3299.865	-99.9959090909	3300	6180	0.1081	1932856	752.36626584	CS

HEPA - Frequently Asked Questions (FAQ)

What is the current Hepion Pharmaceuticals share price?

The current share price of Hepion Pharmaceuticals is $ 0.135

How many Hepion Pharmaceuticals shares are in issue?

Hepion Pharmaceuticals has 10,976,276 shares in issue

What is the market cap of Hepion Pharmaceuticals?

The market capitalisation of Hepion Pharmaceuticals is USD 1.48M

What is the 1 year trading range for Hepion Pharmaceuticals share price?

Hepion Pharmaceuticals has traded in the range of $ 0.1081 to $ 56.00 during the past year

What is the PE ratio of Hepion Pharmaceuticals?

The price to earnings ratio of Hepion Pharmaceuticals is -0.11

What is the reporting currency for Hepion Pharmaceuticals?

Hepion Pharmaceuticals reports financial results in USD

What is the latest annual profit for Hepion Pharmaceuticals?

The latest annual profit of Hepion Pharmaceuticals is USD -13.19M

What is the registered address of Hepion Pharmaceuticals?

The registered address for Hepion Pharmaceuticals is 1209 ORANGE STREET, NEW CASTLE, WILMINGTON, DELAWARE, 19801

What is the Hepion Pharmaceuticals website address?

The website address for Hepion Pharmaceuticals is www.hepion.com

Which industry sector does Hepion Pharmaceuticals operate in?

Hepion Pharmaceuticals operates in the PHARMACEUTICAL PREPARATIONS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
YHCLQR House Inc	$ 10.76 (172.41%)	49.7M
NUWENewellis Inc	$ 15.94 (131.18%)	40.03M
APMAptorum Group Ltd	$ 1.93 (99.01%)	196.41M
RGTXDefiance Daily Target 2X Long RGTI ETF	$ 56.25 (60.49%)	3.24M
DTSTData Storage Corporation	$ 5.2952 (56.66%)	14.95M
ZVSAZyVersa Therapeutics Inc	$ 0.31 (-43.53%)	12.45M
CGBSCrown LNG Holdings Ltd	$ 0.03795 (-38.09%)	197.49M
CYCCCyclacel Pharmaceuticals Inc	$ 8.16 (-33.82%)	3.55M
NCPLNetcapital Inc	$ 3.2519 (-28.53%)	2.22M
JUNSJupiter Neurosciences Inc	$ 2.125 (-28.45%)	929.83k
GTIGraphjet Technology	$ 0.102 (39.73%)	452.35M
OPENOpendoor Technologies Inc	$ 1.49 (43.27%)	303.74M
IXHLIncannex Healthcare Ltd	$ 0.3869 (13.79%)	284.9M
CGBSCrown LNG Holdings Ltd	$ 0.03795 (-38.09%)	197.47M
APMAptorum Group Ltd	$ 1.93 (99.01%)	196.41M